Subscribe To

Price Alert Latest News Economic Calendar News

EPWCF / Empower Clinics launches first Health Canada-approved Vitamin D home testing kit

Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF) said its subsidiary Medisure has launched a rapid Vitamin D test kit, the first Health Canada-approved at-home testing solution, with sales to begin next month. "The launch and pre-sales of this Vitamin D at-home testing solution is a perfect execution of our vision of being a leading integrated healthcare company," Steven McAuley, chairman and CEO of Empower Clinics said in a statement. Read More

Demo Live Account See Partner Details

Content Topics

Empower

Clinics

Launches

First

Health

Canada

Approved

Canada approved

Vitamin

Testing

Stock

EPWCF

Posted: Apr 25 2022, 06:44

Author Name: Proactive Investors

EPWCF News

By Proactive Investors
June 6, 2023

Empower Clinics signs letter of intent for equity capital facility

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has signed a letter of intent (LOI) with Crescita Capital LLC for a C$5 million equity capital f

By Proactive Investors
May 9, 2023

Empower Clinics looks to expand research opportunities, utilize financial advisor to grow shareholder value

Empower Clnincs Inc. has released a corporate update covering its developing research and clinical trials divisions. Last month, Empower subsidiary

By Proactive Investors
May 3, 2023

Empower Clinics signs fourth principal investigator for Dallas site

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) announced that it has signed another agreement for a principal investigator (PI) at its research and clini

By Proactive Investors
April 25, 2023

Empower Clinics adds two new researchers to support clinical trials services at its site in Dallas

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said its subsidiary, EPW Curesearch LLC, has signed two new research services agreements with leading phys

By Proactive Investors
April 17, 2023

Empower Clinics signs clinical trials services deal with Texas medical group

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has announced an agreement to develop a program for research and clinical trials services with a Dallas, T

By Proactive Investors
March 21, 2023

Empower Clinics commences process to explore and evaluate strategic options

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has commenced a process to explore and evaluate strategic options to enhance and preserve shareho

By Proactive Investors
March 7, 2023

Empower Clinics advances partnership to launch US clinical trial management services

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has said its previously announced LOI (letter of intent) to create and operate a Dallas-based Site Manage

By Proactive Investors
March 1, 2023

Empower Clinics ends Q4 2022 with $193,144 in cash; continues to focus on clinical trial services

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has said it held $193,144 in cash at end-2022 as it announced its interim results for the fourth quarter t

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.